Sabra Healthcare REIT (NASDAQ:SBRA) Coverage Initiated by Analysts at Huntington Sec

Huntington Sec started coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a research report released on Monday,Zacks reports. The brokerage issued a strong-buy rating on the real estate investment trust’s stock.

Other equities analysts have also issued reports about the company. Wells Fargo & Company dropped their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Mizuho set a $21.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, August 31st. UBS Group dropped their price objective on shares of Sabra Healthcare REIT from $21.00 to $20.00 and set a “neutral” rating on the stock in a report on Tuesday, October 13th. Truist Financial boosted their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Finally, Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $21.50.

Sabra Healthcare REIT Stock Up 3.2%

SBRA stock opened at $20.35 on Monday. Sabra Healthcare REIT has a twelve month low of $17.53 and a twelve month high of $22.77. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The company has a market cap of $5.20 billion, a price-to-earnings ratio of 72.68, a P/E/G ratio of 1.79 and a beta of 0.68. The business has a 50 day moving average price of $19.85 and a two-hundred day moving average price of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.05). The company had revenue of $249.57 million for the quarter, compared to the consensus estimate of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.56% and a net margin of 7.78%. The business’s quarterly revenue was up 31.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.38 EPS. Analysts anticipate that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Stockholders of record on Friday, November 13th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

Insider Activity at Sabra Healthcare REIT

In other news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.09% of the stock is owned by insiders.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently modified their holdings of the business. Nissay Asset Management Corp Japan raised its holdings in Sabra Healthcare REIT by 1.5% during the second quarter. Nissay Asset Management Corp Japan now owns 38,957 shares of the real estate investment trust’s stock valued at $760,000 after acquiring an additional 585 shares during the period. Versant Capital Management Inc lifted its position in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 603 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Sabra Healthcare REIT by 7.9% in the third quarter. GAMMA Investing LLC now owns 9,927 shares of the real estate investment trust’s stock worth $196,000 after acquiring an additional 724 shares during the period. Anchor Investment Management LLC boosted its stake in shares of Sabra Healthcare REIT by 17.8% in the second quarter. Anchor Investment Management LLC now owns 4,877 shares of the real estate investment trust’s stock worth $95,000 after acquiring an additional 737 shares during the period. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of Sabra Healthcare REIT by 1.5% in the third quarter. Oregon Public Employees Retirement Fund now owns 52,885 shares of the real estate investment trust’s stock worth $1,043,000 after acquiring an additional 800 shares during the period. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT News Summary

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 guidance: EPS is now projected at $1.54–$1.55, above the $1.52 consensus, and the midpoint of normalized FFO guidance increased by $0.005 per share. Management also expects 7%–8% year-over-year earnings growth. Sabra Health Care: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Third-quarter revenue of about $249.6 million exceeded analyst estimates of $236.6 million and rose 31.4% year over year. Adjusted FFO also topped consensus, according to Zacks. Sabra Healthcare Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Senior-housing operating portfolio occupancy reached 89.2%, supporting the company’s growth outlook. Sabra also declared a quarterly dividend of $0.30 per share, equivalent to a 6.0% yield based on the provided data. Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
• Neutral Sentiment: Sabra aims to increase its senior housing operating portfolio (SHOP) to 50% of its portfolio by year-end 2027, while management sees further upside from nursing-home asset optimization and lease negotiations. The strategy offers growth potential but depends on execution. Sabra Expects Earnings Growth and Targets More SHOP Exposure
• Negative Sentiment: Reported third-quarter net income was $0.11 per diluted share, below the $0.16 analyst consensus and down from $0.38 a year earlier. This earnings miss may temper the positive impact of stronger revenue, FFO, and guidance. Sabra Q3 Earnings Results

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.